Abstract-Bay K 8644 caused no significant effects on the 3H overflow and con traction evoked by electrical stimulation in the canine saphenous vein preloaded with [3H]norepinephrine.
We previously reported that Ca antagonists inhibited the depolarization-evoked norepine phrine (NE) release from the adrenergic nerve endings (1, 2) . The concentration range of the Ca antagonists required to inhibit the NE release, however, appears to be con siderably higher than that needed to relax vascular smooth muscle (3) , suggesting the possibility that Ca2+ channels in the adre nergic nerve endings may differ from those in vascular smooth muscle membrane. Recently, Bay K 8644 was reported to act as a Ca 21 channel agonist in cardiac and vascular smooth muscle cells (4) . To further examine the property of Ca2+ channels in the adre nergic nerve endings, we investigated the effects of Bay K 8644 on the electrically stimulated and KCI-evoked 3H overflow and contraction in the canine saphenous vein preloaded with [3H]NE.
Helical strips of the saphenous vein isolated from mongrel dogs, weighing 10-28 kg, were incubated for 2 hr with 8.6 x 10-8 M 1 -[7-3H] NE (New England Nuclear, specific activity of 23.1 Ci/mmol) and then superfused at a rate of 3.6 ml/min with Krebs-bicarbonate (Krebs') solution maintained at 37°C and bubbled with 95% 02 and 5% CO2. After equilibration, the veins were either electrically stimulated (150 pulses, 10 Hz, 20 V, 0.3 msec) at 16 min intervals or exposed to 40 mM KCI solution for 6 (7) or an increase in the probability of channel opening in response to depolarizing stimuli (8), both of which lead to an increase in Ca2+ influx, and since the increased influx of Ca2+ into the nerve endings through the voltage-dependent Ca2+ channels triggers the neurotransmitter release evoked by KCI (9) . In contrast to the KCI-evoked overflow, as shown in Fig. 2 , Bay K 8644 at stepwise increasing concentrations was superfused 10 min before onset of the 6-min application of 40 mM KCI (S3 to S8). Nisoldipine was superfused 10 min before onset of S3 to 22 min after onset of S8. The radioactivities in the 2-min sample just before the second application of 40 mM KCI (S2) and in the four 2-min samples after S2 were 3213±1 54 and 23811 ±1441 dpm (n=1 5), respectively. The corresponding increase in the tension was 3.21 ±0.23 g. Values are expressed as the mean±S.E.M. from 5 veins. *P<0.05 **P<0 .01, significantly different from control. *P<0.05, **P<0.01, significantly different from Bay K 8644 alone. and 7978±798 dpm (n=8), respectively. The corresponding increase in the tension was 3.44±0.52 g. Values are expressed as the mean±S.E.M. from 4 veins. the electrically stimulated 3H overflow was not enhanced by Bay K 8644 (10-7-3x10-5 M). This result is in agreement with the finding by Hyland et al. (10) using the isolated rat vas deferens. Therefore, it may be assumed that there are differences in the number or properties of Ca2+ channels in the adrenergic nerve endings that are activated by the two modes of stimulation. The failure of Bay K 8644 to affect spontaneous 3H overflow suggests that the agent does not act on Ca channels under the condition where the channels are not stimulated.
Bay K 8644 failed to significantly enhance the contraction induced by the two modes of stimulation ( Figs. 1 and 2 ). We recently reported that 3x10-4 M 4-aminopyridine augmented electrically evoked release of NE 2.7-fold. while it enhanced the con traction only 1.3-fold (11) . The preseni study reveals that the enhancement of the KCI-evoked overflow by Bay K 8644 is insufficient for the significant potentiation of the contraction. This seems to be the reason why Bay K 8644 failed to significantly enhance the contraction in spite of a sig nificant increase in the evoked overflow.
As shown in Fig. 1 , nisoldipine (10-6 M) significantly suppressed the KCI-evoked con traction in the veins treated with Bay K 8644, compared with that in the control veins or in the veins treated with Bay K 8644 alone, although the evoked overflow from the Bay K 8644-treated veins in the presence of nisoldipine was of almost the same degree as that from the control veins. Nisoldipine per se caused a significant inhibition of the KCI-evoked contraction. The inhibitory effeci was equipotent to that seen with the Bay K 8644-treated veins. These findings suggesl that the significant inhibition of the KCI evoked contraction by nisoldipine may be attributable to a direct action of nisoldipine on the venous smooth muscle.
It is concluded that there is a difference between the modes of action of Bay K 8644 on NE releases evoked by electrical stimu lation and KCI.
